Table 1.
Characteristics of presumptive TB clients seen between 2012 and 2016
| Variables | 2012 n = 274 (%) |
2013 n = 400 (%) |
2014 n = 496 (%) |
2015 n = 505 (%) |
2016 n = 822 (%) |
Total n = 2497 (%) |
| Age group | ||||||
| 0–14 | 4 (1.5) | 8 (2.0) | 12 (2.4) | 11 (2.2) | 12 (1.5) | 47 (1.9) |
| 15–24 | 45 (16.4) | 60 (15.0) | 58 (11.7) | 61 (12.1) | 93 (11.3) | 317 (12.7) |
| 25–34 | 70(25.5) | 100 (25.0) | 108 (21.8) |
169 (33.5) | 180 (21.9) | 627 (25.1) |
| 35–44 | 68 (24.8) | 106 (26.5) | 127 (25.6) |
107 (21.2) | 249 (30.3) | 657 (26.3) |
| 45–54 | 51 (18.6) | 80 (20.0) | 110 (22.2) |
48 (9.5) | 176 (21.4) | 465 (18.6) |
| 55–64 | 24 (8.8) | 32 (8.0) | 50 (10.1) | 55 (10.9) | 83 (10.1) | 244 (9.8) |
| ≥ 65 | 12 (4.4) | 14 (3.5) | 31 (6.3) | 54 (10.7) | 29 (3.5) | 140 (5.6) |
| Gender | ||||||
| Male | 154 (56.2) | 229 (57.3) | 277 (55.8) |
247 (48.9) | 466 (56.7) | 1373 (55.0) |
| Female | 120 (43.8) | 171 (42.8) | 219 (44.2) |
258 (51.1) | 356 (43.3) | 1124 (45.0) |
| HIV result | ||||||
| Positive | 33 (12.0) | 156 (39.0) | 160 (32.3) |
200 (39.6) | 312 (38.0) | 861 (34.5) |
| Negative | 161 (58.8) | 161 (40.3) | 320 (64.5) |
282 (55.8) | 487 (59.2) | 1411 (56.5) |
| Unknown | 80 (29.2) | 83 (20.8) | 16 (3.2) | 23 (4.6) | 23 (2.8) | 225 (9.0) |
| MTB detection | ||||||
| Negative | 118 (43.1) | 170 (42.5) | 274 (55.2) |
388 (76.8) | 439 (53.4) | 1389 (55.6) |
| Positive | 135 (49.3) | 181 (45.3) | 216 (43.5) |
94 (18.6) | 316 (38.4) | 942 (37.7) |
| invalid | 21 (7.7) | 49 (12.3) | 6 (1.2) | 23 (4.6) | 67 (8.2) | 166 (6.6) |
|
Rifampicin resistance |
n = 135 (%) | n = 181 (%) | n = 216 (%) |
n = 94 (%) | n = 316 (%) | n = 942 (%) |
| No | 69 (51.1) | 124 (68.5) | 182 (82.3) |
72 (76.6) | 275 (87.0) | 722 (76.6) |
| Yes | 66 (48.9) | 57 (31.5) | 34 (15.7) | 22 (23.4) | 41 (13.0) | 220 (23.4) |